These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


753 related items for PubMed ID: 9253354

  • 1. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
    Yamaguchi S, Yachiku S, Morikawa M.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
    [Abstract] [Full Text] [Related]

  • 2. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
    Demıralay E, Altaca G, Demırhan B.
    Turk Patoloji Derg; 2011 Aug; 27(3):215-20. PubMed ID: 21935871
    [Abstract] [Full Text] [Related]

  • 3. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
    Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis RA.
    Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
    [Abstract] [Full Text] [Related]

  • 4. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
    Suzuki S, Tsuchiya A, Hara K, Abe R.
    Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
    [Abstract] [Full Text] [Related]

  • 5. Assessment of proliferative activity of glandular cells in hyperfunctioning parathyroid gland using flow cytometric and immunohistochemical methods.
    Xiao-Lin P, Koide N, Kobayashi S, Kobayashi M, Sugenoya A, Iida F, Katsuyama T, Usuda N, Nagata T.
    World J Surg; 1996 Jun; 20(3):361-6; discussion 367. PubMed ID: 8661846
    [Abstract] [Full Text] [Related]

  • 6. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
    Mangili F, Sassi I, Schiaffino E, Zogno C, Cantaboni A, Schmid C.
    Pathologica; 1992 Jun; 84(1092):459-65. PubMed ID: 1491887
    [Abstract] [Full Text] [Related]

  • 7. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O, Moore FD, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [Abstract] [Full Text] [Related]

  • 8. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
    Hosokawa S.
    Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
    [Abstract] [Full Text] [Related]

  • 9. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ, Seo UH, Kim WY, Woo SU, Lee JB.
    J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
    [Abstract] [Full Text] [Related]

  • 10. Parathyroid adenomas and glands in normocalcemic hyperparathyroidism. A light microscopic study.
    Grimelius L, Ejerblad S, Johansson H, Werner I.
    Am J Pathol; 1976 Jun; 83(3):475-84. PubMed ID: 937508
    [Abstract] [Full Text] [Related]

  • 11. MIB-1 proliferative index in parathyroid adenoma & hyperplasia.
    Karak AK, Sarkar C, Chumber S, Tandon N.
    Indian J Med Res; 1997 May; 105():235-8. PubMed ID: 9183080
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 13. Peroperative evaluation of parathyroid glands using fat stain on frozen sections. Advantages and limitations.
    Farnebo LO, von Unge H.
    Acta Chir Scand Suppl; 1984 Apr; 520():17-24. PubMed ID: 6209877
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
    Thomopoulou GE, Tseleni-Balafouta S, Lazaris AC, Koutselini H, Kavantzas N, Davaris PS.
    Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
    [Abstract] [Full Text] [Related]

  • 15. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
    Letizia C, Ricci F, De Toma G, Cianci R, Alo P, Celi M, Panzironi G, Mingazzini PL, D'Erasmo E, Mazzuoli GF.
    Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
    [Abstract] [Full Text] [Related]

  • 16. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings.
    Takebayashi S, Hidai H, Chiba T, Takagi Y, Nagatani Y, Matsubara S.
    J Nucl Med; 1999 Nov; 40(11):1792-7. PubMed ID: 10565772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN, Kayath MJ, Vieira JG, Nosé-Alberti V.
    Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.